1 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
While AI can contribute to other areas like automating tasks or potentially influencing research, its core purpose in medical imaging is to enhance the interpretation of images, leading to better diagnoses and treatment plans. |
from www.ibm.com |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
AI algorithms can analyze medical images and provide insights that might be missed by human radiologists. This acts as a "second set of eyes," helping to improve diagnostic accuracy and reduce errors |
from www.spectral-ai.com |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
It encompasses a broad understanding of what AI is, how it works, its capabilities and limitations, its ethical implications, and its societal impact. It doesn't necessarily mean being able to build or repair AI systems, but rather having a fundamental grasp of the concepts and their relevance to various aspects of life. |
from www.ipu.org & dai.ki |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
The color of the machines is irrelevant to their functionality or how well they integrate into medical workflows and would not influence professional acceptance. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
how the opinions and experiences of colleagues, peers, and other influential figures in the healthcare field can impact an individual's willingness to adopt and use AI technologies. |
http://pmc.ncbi.nlm.nih.gov/ |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
While AI is intended to assist professionals, not replace them entirely, there are anxieties that widespread adoption of AI could eventually lead to job displacement in certain areas of healthcare. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
essential for increasing AI acceptability among medical professionals. This means AI systems should be designed |
http://pubmed.ncbi.nlm.nih.gov/ |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
This category focuses on the practical aspects of using the AI system. It addresses questions |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
Doctors, nurses, and other healthcare providers are bound by ethical codes that prioritize patient well-being, fairness, transparency, and accountability. If an AI system's design or application conflicts with these values |
http://www.ama-assn.org/ |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
considering user experience and system integration deeply for future AI acceptability studies. A user-centered approach is crucial. Simply focusing on technical performance is insufficient. Understanding how healthcare professionals interact with AI systems, their needs, concerns, and workflows |
http://www.researchgate.net/ |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
to replace lost dopamine neurons. Parkinson's is characterized by the degeneration of these dopamine-producing cells in a specific brain region. |
http://www.ninds.nih.gov/ |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Monkeys |
|
Monkeys were used to test the STEM-PD product for safety and efficacy. Preclinical studies often use non-human primates like monkeys because their physiology and brain structure |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
12 months |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
15 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
under GMP-compliant conditions. GMP stands for Good Manufacturing Practices. These are regulations that ensure products are consistently produced and controlled according to quality standards. |
http://pubmed.ncbi.nlm.nih.gov/ |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
This is a crucial finding in preclinical safety studies, as it suggests the treatment is well-tolerated and doesn't pose significant risks |
http://pubmed.ncbi.nlm.nih.gov/ |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells reversed motor deficits in rats. |
|
This suggests the treatment has the potential to improve motor function, which is a primary symptom of Parkinson's disease. |
http://www.medicalnewstoday.com/ |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
GIRK2 and ALDH1A1 |
|
GIRK2 and ALDH1A1. These are markers specifically associated with midbrain dopamine neurons, the cell type that is depleted in Parkinson's diseas |
http://www.researchgate.net/ |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are used in cell patterning for specific neural fates. |
|
because they are used in cell patterning for specific neural fates. These growth factors act as signaling molecules that guide the stem cells to differentiate into the desired cell type, specifically midbrain dopamine neurons. |
http://journals.physiology.org/ & http://royalsocietypublishing.org/ |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
|
recovery of motor function. Parkinson's disease primarily affects motor skills, so improvements in movement and coordination are crucial indicators of a potential treatment's effectiveness. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|